<code id='9DCAB55016'></code><style id='9DCAB55016'></style>
    • <acronym id='9DCAB55016'></acronym>
      <center id='9DCAB55016'><center id='9DCAB55016'><tfoot id='9DCAB55016'></tfoot></center><abbr id='9DCAB55016'><dir id='9DCAB55016'><tfoot id='9DCAB55016'></tfoot><noframes id='9DCAB55016'>

    • <optgroup id='9DCAB55016'><strike id='9DCAB55016'><sup id='9DCAB55016'></sup></strike><code id='9DCAB55016'></code></optgroup>
        1. <b id='9DCAB55016'><label id='9DCAB55016'><select id='9DCAB55016'><dt id='9DCAB55016'><span id='9DCAB55016'></span></dt></select></label></b><u id='9DCAB55016'></u>
          <i id='9DCAB55016'><strike id='9DCAB55016'><tt id='9DCAB55016'><pre id='9DCAB55016'></pre></tt></strike></i>

          focus

          focus

          author:focus    Page View:24858
          Novo Nordisk headquarters -- health coverage from STAT
          LISELOTTE SABROE/Scanpix/AFP via Getty Images

          LONDON — Novo Nordisk said Monday it would acquire the German firm Cardior Pharmaceuticals in a deal worth up to $1.1 billion, picking up additional drug candidates for its pipeline of cardiometabolic medicines. 

          Cardior focuses on targeting RNA to address the root causes of heart disease. Its lead candidate, known CDR132L, is in Phase 2 development as a treatment for health failure. 

          advertisement

          The companies did not disclose how much Novo was paying upfront for Cardior and how much would be based on future milestones being achieved. The deal is expected to close in the second quarter.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more
          Roche acquires Telavant from Roivant, adding experimental IBD treatment
          Roche acquires Telavant from Roivant, adding experimental IBD treatment

          SebastienBozon/AFPviaGettyImagesRochesaidMondayitwasbuyingTelavantHoldingsfor$7.1billionupfront,pick

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          Liz Cheney makes 1st public comment since Trump's election interference indictments

          16:56Rep.LizCheney(R-Wyo.)astheJanuary6thCommitteemeetsforitsfinalsessionattheCannonHouseOfficeBuild